123 related articles for article (PubMed ID: 2610124)
1. Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines.
Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Kiriyama Y; Mikawa H
Adv Exp Med Biol; 1989; 253B():363-7. PubMed ID: 2610124
[No Abstract] [Full Text] [Related]
2. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
Kubota M; Takimoto T; Tanizawa A; Akiyama Y; Mikawa H
Biochem Pharmacol; 1988 May; 37(9):1745-9. PubMed ID: 2454114
[TBL] [Abstract][Full Text] [Related]
3. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
Abe I; Saito S; Hori K; Suzuki M; Sato H
Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
[TBL] [Abstract][Full Text] [Related]
4. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
Tanaka M; Yoshida S
Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
Roberts D; Peck C; Hilliard S; Wingo W
Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642
[TBL] [Abstract][Full Text] [Related]
6. Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C.
Plunkett W; Liliemark JO; Estey E; Keating MJ
Semin Oncol; 1987 Jun; 14(2 Suppl 1):159-66. PubMed ID: 3589690
[No Abstract] [Full Text] [Related]
7. Relationship between intracellular dCTP/ara-CTP ratio and cytotoxic effect of ara-C.
Kawasaki H; Higashigawa M; Ohkubo T; Kamiya H; Sakurai M
Adv Exp Med Biol; 1989; 253B():369-74. PubMed ID: 2610125
[No Abstract] [Full Text] [Related]
8. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
Gandhi V; Plunkett W
Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008
[TBL] [Abstract][Full Text] [Related]
9. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
Grant S; Bhalla K; McCrady C
Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
Gandhi V; Plunkett W
Cancer Chemother Pharmacol; 1992; 31(1):11-7. PubMed ID: 1458554
[TBL] [Abstract][Full Text] [Related]
11. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
[TBL] [Abstract][Full Text] [Related]
12. Prediction of sensitivity to 1-beta-D-arabinofuranosylcytosine by the plateau level of its 5'-triphosphate in human lymphoblastic cell lines in vitro.
Abe I; Saito S; Hori K; Suzuki M; Sato H
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):941-4. PubMed ID: 6576907
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
Snyder RD; Malick NC
Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913
[TBL] [Abstract][Full Text] [Related]
14. Effect of m-AMSA on the cellular pharmacology of ara-CTP in human leukemic cells during therapy with high-dose ara-C.
Plunkett W; Keating M
Adv Exp Med Biol; 1986; 195 Pt B():171-5. PubMed ID: 3766228
[No Abstract] [Full Text] [Related]
15. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
Zittoun J; Marquet J; David JC; Maniey D; Zittoun R
Cancer Chemother Pharmacol; 1989; 24(4):251-5. PubMed ID: 2752506
[TBL] [Abstract][Full Text] [Related]
16. Increase in the cytotoxicity of 1-beta-D-arabinofuranosylcytosine due to inhibition of degradation of its triphosphate by hydroxyurea in Burkitt's lymphoma cells.
Abe I; Saito S; Suzuki M; Sato H
Gan; 1981 Apr; 72(2):337-8. PubMed ID: 7286558
[No Abstract] [Full Text] [Related]
17. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
Liliemark JO; Plunkett W
Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Hug V; Keating MJ; Chubb S
Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
[TBL] [Abstract][Full Text] [Related]
19. Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line.
Tanizawa A; Kubota M; Takimoto T; Kito T; Akiyama Y; Kiriyama Y; Mikawa H
Adv Exp Med Biol; 1989; 253B():349-54. PubMed ID: 2610122
[No Abstract] [Full Text] [Related]
20. Intracellular dCTP/ara-CTP ratio and the cytotoxic effect of ara-C.
Kawasaki H; Kuwabara H; Hori H; Higashigawa M; Ohkubo T; Sakurai M
Cancer Invest; 1991; 9(4):409-13. PubMed ID: 1884247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
